Richard H. Chapman

11.6k citations

69 papers · 3.9k indexed · 1 hit paper · h-index 32

Family Practice top 0.2%
- Medication Adherence and Compliance 10
Geriatrics and Gerontology top 1%
- Pharmaceutical Practices and Patient Outcomes 7
Biochemistry top 1%
- Blood transfusion and management 6
Economics and Econometrics top 0.5%
- Health Systems, Economic Evaluations, Quality of Life 30
- Healthcare Policy and Management 10
Endocrinology, Diabetes and Metabolism top 2%
- Diabetes Management and Research 6
- Diabetes, Cardiovascular Risks, and Lipoproteins 6
General Health Professions
- Healthcare cost, quality, practices 9

Co-authors: Peter J. Neumann Patricia W. Stone Eileen A. Sandberg Chaim M. Bell Susan Grandy Harold Bays Douglas M. Surgenor Edward L. Wallace
Cited by: Family Practice Geriatrics and Gerontology Biochemistry
Journals: New England Journal of Medicine (1 paper)Journal of Clinical Oncology (1 paper)Annals of Internal Medicine (2 papers)
Partner nations: United States United Kingdom Canada

In The Last Decade

Richard H. Chapman

68 papers receiving 3.7k citations

Hit Papers

align trajectories log scale

Peers

Countries citing papers authored by Richard H. Chapman

Since Specialization

Citations

This map shows the geographic impact of Richard H. Chapman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard H. Chapman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard H. Chapman more than expected).

Fields of papers citing papers by Richard H. Chapman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard H. Chapman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard H. Chapman. The network helps show where Richard H. Chapman may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Richard H. Chapman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Richard H. Chapman Line = papers co-authored together Richard H. Chapman links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	HTA Evidence in Rare Diseases: Just Rare or Also Special? PharmacoEconomics ·Anirban Basu,Simu K. Thomas,Richard H. Chapman,Jason Spangler	2025	1
2	Preferences for Treatments for Major Depressive Disorder: Formative Qualitative Research Using the Patient Experience Patient ·Susan dosReis,Laura M. Bozzi,Beverly Butler,Richard Xie,Richard H. Chapman,Jennifer Bright,Erica Malik,Julia F. Slejko	2022	3
3	Does Cost-Effectiveness Analysis Overvalue Potential Cures? Exploring Alternative Methods for Applying a “Shared Savings” Approach to Cost Offsets Value in Health ·Richard H. Chapman,Varun Kumar,Melanie D. Whittington,Steven D. Pearson	2021	6
4	Modeling Medicaid and Medicare Savings from Reduced Poverty and Disability to Promote Investment in Mental Health and Substance Use Interventions in the USA Applied Health Economics and Health Policy ·Nathaniel Z. Counts,Paul Gionfriddo,Richard H. Chapman	2020	1
5	Cost effectiveness of nusinersen for patients with infantile-onset spinal muscular atrophy in US Cost Effectiveness and Resource Allocation ·Praveen Thokala,Matt Stevenson,Varun Kumar,Shijie Ren,Alexandra G. Ellis,Richard H. Chapman	2020	23
6	Cost-Effectiveness of Ivacaftor Therapy for Treatment of Cystic Fibrosis Patients With the G551D Gating Mutation Value in Health ·Kael Wherry,Ian O. Williamson,Richard H. Chapman,Karen M. Kuntz	2020	3
7	Disease-Modifying Therapies for Relapsing–Remitting and Primary Progressive Multiple Sclerosis: A Cost-Utility Analysis CNS Drugs ·Marita Zimmermann,Elizabeth Brouwer,Jeffrey A. Tice,Matt Seidner,Anne Loos,Shanshan Liu,Richard H. Chapman,Varun Kumar,Josh J. Carlson	2018	35
8	Assessing the value of mepolizumab for severe eosinophilic asthma: a cost-effectiveness analysis Annals of Allergy Asthma & Immunology ·Melanie D. Whittington,R. Brett McQueen,Daniel A. Ollendorf,Jeffrey A. Tice,Richard H. Chapman,Steven D. Pearson,Jonathan D. Campbell	2016	64
9	PDB51 Medication Adherence and Medical Costs Associated With Exenatide Bid Versus Liraglutide: A Retrospective Database Analysis Value in Health ·E.M. Pelletier,Manjiri Pawaskar,Richard H. Chapman	2012	1
10	Drug titration patterns and HbA_1clevels in type 2 diabetes International Journal of Clinical Practice ·J. Ross Maclean,Richard H. Chapman,Cheryl P Ferrufino,Girishanthy Krishnarajah	2009	5
11	Quality of life and depression of people living with type 2 diabetes mellitus and those at low and high risk for type 2 diabetes: findings from the Study to Help Improve Early evaluation and management of risk factors Leading to Diabetes (SHIELD) International Journal of Clinical Practice ·Susan Grandy,Richard H. Chapman,Kathleen M. Fox,(unknown)	2008	78
12	Predictors of Adherence to Concomitant Antihypertensive and Lipid-Lowering Medications in Older Adults Drugs & Aging ·Richard H. Chapman,Allison Petrilla,Joshua S. Benner,J. Sanford Schwartz,Simon Tang	2008	89
13	Prevalence of self-reported diagnosis of diabetes mellitus and associated risk factors in a national survey in the US population: SHIELD (Study to Help Improve Early evaluation and management of risk factors Leading to Diabetes) BMC Public Health ·Harold Bays,Debbra D. Bazata,Nathaniel G. Clark,James R. Gavin,Andrew Green,Sandra Lewis,Michael L. Reed,Walter F. Stewart,Richard H. Chapman,Kathleen M. Fox,Susan Grandy	2007	66
14	The relationship of body mass index to diabetes mellitus, hypertension and dyslipidaemia: comparison of data from two national surveys International Journal of Clinical Practice ·Harold Bays,Richard H. Chapman,Susan Grandy,(unknown)	2007	389
15	Integrating cost-effectiveness evidence into clinical practice guidelines in Australia for acute myocardial infarction The European Journal of Health Economics ·Kathryn Antioch,Garry Jennings,Mari Botti,Richard H. Chapman,V. Wulfsohn	2002	9
16	Cost-utility analyses of clinical preventive services American Journal of Preventive Medicine ·Patricia W. Stone,Steven M. Teutsch,Richard H. Chapman,Chaim M. Bell,Sue J. Goldie,Peter J. Neumann	2000	90
17	MEASURING COSTS IN COST-UTILITY ANALYSES International Journal of Technology Assessment in Health Care ·Patricia W. Stone,Richard H. Chapman,Eileen A. Sandberg,Bengt Liljas,Peter J. Neumann	2000	107
18	The Collaborative Hospital Transfusion Study: variations in use of autologous blood account for hospital differences in red cell use during primary hip and knee surgery Transfusion ·W. H. Churchill,Siobhan McGurk,Richard H. Chapman,Edward L. Wallace,M.F. Bertholf,Lawrence T. Goodnough,Kuo-Jang Kao,John D. Olson,Robert D. Woodson,Douglas M. Surgenor	1998	32
19	Blood Product Utilization in Hip and Knee Arthroplasty: Effect of Gender and Autologous Blood on Transfusion Practice Vox Sanguinis ·W. H. Churchill,Richard H. Chapman,Cynthia Rutherford,Robert Poss,Edward L. Wallace,Douglas M. Surgenor	1994	27
20	Collection and Transfusion of Blood in the United States, 1982–1988 New England Journal of Medicine ·Douglas M. Surgenor,Edward L. Wallace,Steven H.S. Hao,Richard H. Chapman	1990	197

About Richard H. Chapman

Richard H. Chapman is a scholar working on Family Practice, Geriatrics and Gerontology and Economics and Econometrics, having authored 69 papers that have together received 3.9k indexed citations. Recurring topics across this work include Health Systems, Economic Evaluations, Quality of Life (30 papers), Medication Adherence and Compliance (10 papers), Healthcare Policy and Management (10 papers), Healthcare cost, quality, practices (9 papers), Pharmaceutical Practices and Patient Outcomes (7 papers), Blood transfusion and management (6 papers), Diabetes Management and Research (6 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (6 papers). The work is most often cited by research in Family Practice (490 citations), Geriatrics and Gerontology (335 citations) and Biochemistry (332 citations). Richard H. Chapman has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Peter J. Neumann, Patricia W. Stone, Eileen A. Sandberg, Chaim M. Bell, Susan Grandy, Harold Bays, Douglas M. Surgenor, Edward L. Wallace, Steven D. Pearson and Daniel A. Ollendorf. Their work appears in journals such as New England Journal of Medicine, Journal of Clinical Oncology and Annals of Internal Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact